Bio-synthesis, purification and structural analysis of Cyclosporine-A produced by Tolypocladium inflatum with valorization of agro-industrial wastes.
Tolypocladium inflatum
Chemical structure
Cyclosporine
Purification
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
31 May 2024
31 May 2024
Historique:
received:
01
11
2023
accepted:
24
05
2024
medline:
1
6
2024
pubmed:
1
6
2024
entrez:
31
5
2024
Statut:
epublish
Résumé
Cyclosporine A (CyA) holds significant importance as a strategic immunosuppressive drug for organ transplant patients. In this study, we aimed to produce pure and cost-effective Cyclosporine A (CyA) by fermenting a culture medium containing dairy sludge, using Tolypocladium inflatum PTCC 5253. Following the fermentation stage, ethyl acetate extraction and fast protein liquid chromatography were employed for sample purification. The initial evaluation of the effectiveness of CyA obtained from these processes was performed through bioassay, wherein the antimicrobial clear zone diameter was found to be larger compared to the sample obtained from the fermentation culture. The concentration of CyA was determined using high-performance liquid chromatography, yielding values of 334 mg/L, 456 mg/L, and 578 mg/L for the fermented, extracted, and purified samples, respectively. Further analysis utilizing liquid chromatography tandem mass spectrometry (LC/MS/MS) confirmed a purity of 91.9% and proper agreement with the standard sample based on the ion intensity of Z/m 1205. To validate the structure of CyA, nuclear magnetic resonance spectroscopy, Fourier-transform infrared (FT-IR), and Raman spectroscopy were employed. X-ray diffraction and differential scanning calorimetry analyses demonstrated that the purified CyA exhibited a crystal structure similar to the standard sample, characterized by two broad peaks at 2θ = 9° and 20°, and comparable glass transition temperatures (57-68 °C for the purified sample; 53-64 °C for the standard sample). Dynamic light scattering analysis confirmed a uniform particle size distribution in both the purified and standard samples. The zeta potentials of the purified and standard samples were determined to be - 25.8 ± 0.16 and - 23.63 ± 0.12 mV, respectively. Our results demonstrate that dairy sludge can serve as a suitable culture medium for the production of (CyA).
Identifiants
pubmed: 38822034
doi: 10.1038/s41598-024-63110-y
pii: 10.1038/s41598-024-63110-y
doi:
Substances chimiques
Cyclosporine
83HN0GTJ6D
Industrial Waste
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12540Subventions
Organisme : Ferdowsi University of Mashhad
ID : 3/53741
Organisme : Iran National Science Foundation
ID : 99028947
Informations de copyright
© 2024. The Author(s).
Références
Ghazanfari, N., Fallah, S., Vasiee, A. & Yazdi, F. T. Optimization of fermentation culture medium containing food waste for L-glutamate production using native lactic acid bacteria and comparison with industrial strain. LWT 184, 114871 (2023).
doi: 10.1016/j.lwt.2023.114871
Demain, A. L. Small bugs, big business: The economic power of the microbe. Biotechnol. Adv. 18, 499–514 (2000).
pubmed: 14538099
doi: 10.1016/S0734-9750(00)00049-5
Rao, H. Y., Kamalraj, S. & Jayabaskaran, C. Fascinating fungal endophytes associated with medicinal plants: Recent advances and beneficial applications. In Microbial Endophytes (eds Kumar, A. & Singh, V. K.) 263–289 (Elsevier, 2020).
doi: 10.1016/B978-0-12-818734-0.00011-5
Balasubramaniyam, T., Choi, S.-R., Nathan, V. K., Basu, A. & Lee, J.-H. A new perspective on metabolites and bioactive compounds from fungi. Am. J. Chin. Med. 51, 1795–1821 (2023).
pubmed: 37646144
doi: 10.1142/S0192415X23500799
Bills, G. F. & Gloer, J. B. Biologically active secondary metabolites from the fungi. Microbiol. Spectr. 4(6), 10–1128 (2016).
doi: 10.1128/microbiolspec.FUNK-0009-2016
Das, S. et al. Entrepreneurship with Microorganisms 89–120 (Elsevier, 2024).
doi: 10.1016/B978-0-443-19049-0.00021-9
Devi, R. et al. New and Future Developments in Microbial Biotechnology and Bioengineering 147–161 (Elsevier, 2020).
doi: 10.1016/B978-0-12-820528-0.00010-7
Reino, J. L., Guerrero, R. F., Hernández-Galán, R. & Collado, I. G. Secondary metabolites from species of the biocontrol agent Trichoderma. Phytochem. Rev. 7, 89–123 (2008).
doi: 10.1007/s11101-006-9032-2
Ghanbari, T., Seid Mohammadkhani, H. & Babaeizad, V. Identification of some secondary metabolites produced by four Penicillium species. Mycol. Iran. 1, 107–113 (2014).
Irum, W. & Anjum, T. Production enhancement of Cyclosporin ‘A’by Aspergillus terreus through mutation. Afr. J. Biotechnol. 11, 1736–1743 (2012).
Azam, A., Anjum, T. & Irum, W. Trichoderma harzianum: A new fungal source for the production of cyclosporin. Bangladesh J. Pharmacol. 7, 33–35 (2012).
doi: 10.3329/bjp.v7i1.10084
Amor, K. T., Ryan, C. & Menter, A. The use of cyclosporine in dermatology: Part I. J. Am. Acad. Dermatol. 63, 925–946 (2010).
pubmed: 21093659
doi: 10.1016/j.jaad.2010.02.063
Franke, E. K. & Luban, J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag–cyclophilin A interaction. Virology 222, 279–282 (1996).
pubmed: 8806510
doi: 10.1006/viro.1996.0421
Diamanti, A. P. et al. Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: Modulation of P-glycoprotein function. Clin. Immunol. 138, 9–13 (2011).
pubmed: 21062675
doi: 10.1016/j.clim.2010.10.001
Rao, S. N. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am. J. Ophthalmol. 141, 771–772 (2006).
pubmed: 16564829
doi: 10.1016/j.ajo.2005.11.042
Kitahara, K. & Kawai, S. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol. 19, 238–245 (2007).
pubmed: 17414949
doi: 10.1097/BOR.0b013e328099af80
Dogra, S., Mahajan, R., Narang, T. & Handa, S. Systemic cyclosporine treatment in severe childhood psoriasis: A retrospective chart review. J. Dermatol. Treat. 28, 18–20 (2017).
doi: 10.3109/09546634.2015.1034072
Wagner, H., Kreher, B. & Jurcic, K. In vitro stimulation of human granulocytes and lymphocytes by pico-and femtogram quantities of cytostatic agents. Arzneimittel-forschung 38, 273–275 (1988).
pubmed: 3370075
Price, D. A. et al. Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogue. Org. Biomol. Chem. 15, 2501–2506 (2017).
pubmed: 28266673
doi: 10.1039/C7OB00096K
Falah, F., Vasiee, A., Tabatabaei-Yazdi, F., Moradi, S. & Sabahi, S. Optimization of γ-aminobutyric acid (GABA) production by Lactobacillus spp. from agro-food waste. Biomass Convers. Biorefin. 14, 1–13 (2022).
Survase, S. A., Annapure, U. S. & Singhal, R. S. Gellan gum as immobilization matrix for production of cyclosporin A. J. Microbiol. Biotechnol. 20, 1086–1091 (2010).
doi: 10.4014/jmb.1001.01006
Falah, F., Mortazavi, S. A., Danesh, A., Yazdi, F. T. & Ramezani, M. Production of cyclosporin A by Tolypocladium inflatum using dairy waste medium: optimization and investigation of the effect of ultrasound, high hydrostatic pressure, and pulsed electric field treatments on the morphology of fungus. Biomass Convers. Biorefin. https://doi.org/10.1007/s13399-023-03899-2 (2023).
doi: 10.1007/s13399-023-03899-2
Amorim, M. L., Soares, J., Vieira, B. B., Batista-Silva, W. & Martins, M. A. Extraction of proteins from the microalga Scenedesmus obliquus BR003 followed by lipid extraction of the wet deproteinized biomass using hexane and ethyl acetate. Bioresour. Technol. 307, 123190 (2020).
pubmed: 32213445
doi: 10.1016/j.biortech.2020.123190
Garzón, A. G., Cian, R. E., Aquino, M. E. & Drago, S. R. Isolation and identification of cholesterol esterase and pancreatic lipase inhibitory peptides from brewer’s spent grain by consecutive chromatography and mass spectrometry. Food Funct. 11, 4994–5003 (2020).
pubmed: 32515459
doi: 10.1039/D0FO00880J
Tanseer, S. & Anjum, T. Modification of c and n sources for enhanced production of cyclosporin’a’by Aspergillus terreus. Braz. J. Microbiol. 42, 1374–1383 (2011).
pubmed: 24031766
pmcid: 3768709
doi: 10.1590/S1517-83822011000400019
Yonus, N. et al. Changes in hematological parameters of sprague dawley rats with use of cyclosporine and Nigella sativa. Ann. Abbasi Shaheed Hosp. Karachi Med. Dent. Coll. 25, 211–217 (2020).
doi: 10.58397/ashkmdc.v25i4.412
Falah, F., Vasiee, A., Alizadeh Behbahani, B., Tabatabaee Yazdi, F. & Mortazavi, S. A. Optimization of gamma-aminobutyric acid production by Lactobacillus brevis PML1 in dairy sludge-based culture medium through response surface methodology. Food Sci. Nutr. 9, 3317–3326 (2021).
pubmed: 34136196
pmcid: 8194736
doi: 10.1002/fsn3.2304
Alebooye, P., Falah, F., Vasiee, A., Yazdi, F. T. & Mortazavi, S. A. Spent coffee grounds as a potential culture medium for γ-aminobutyric acid (GABA) production by Levilactobacillus brevis PML1. Lwt 189, 115553 (2023).
doi: 10.1016/j.lwt.2023.115553
Alizadeh Behbahani, B., Jooyandeh, H., Falah, F. & Vasiee, A. Gamma-aminobutyric acid production by Lactobacillus brevis A3: Optimization of production, antioxidant potential, cell toxicity, and antimicrobial activity. Food Sci. Nutr. 8, 5330–5339. https://doi.org/10.1002/fsn3.1838 (2020).
doi: 10.1002/fsn3.1838
pubmed: 33133536
pmcid: 7590294
Sun, W. et al. The effect of particle size on the absorption of cyclosporin a nanosuspensions. Int. J. Nanomed. 17, 1741–1755 (2022).
doi: 10.2147/IJN.S357541
Levent, S., Özcan, S., Geven, A. & Can, N. Ö. A novel and sensitive LC–MS/MS method for the quantitation of ceftiofur in pharmaceutical preparations and milk samples. Comb. Chem. High Throughput Screen. 24, 386–399 (2021).
pubmed: 33176637
doi: 10.2174/1386207323999201110192558
Bernardi, F. et al.
pubmed: 16299069
doi: 10.1529/biophysj.105.074245
Nambiar, R. B. et al. Characterization of an exopolysaccharide produced by Lactobacillus plantarum HM47 isolated from human breast milk. Process Biochem. 73, 15–22 (2018).
doi: 10.1016/j.procbio.2018.07.018
Yu, X., Li, W., Liang, O., Bai, Y. & Xie, Y.-H. Molecular orientation and specificity in the identification of biomolecules via surface enhanced Raman spectroscopy. Anal. Biochem. 599, 113709 (2020).
pubmed: 32298641
doi: 10.1016/j.ab.2020.113709
Sun, W., Tian, Y., Wang, Z., Zhang, H. & Zheng, A. The study of cyclosporin A nanocrystals uptake and transport across an intestinal epithelial cell model. Polymers 14, 1975 (2022).
pubmed: 35631858
pmcid: 9147483
doi: 10.3390/polym14101975
Ayala-Torres, C., Hernández, N., Galeano, A., Novoa-Aponte, L. & Soto, C.-Y. Zeta potential as a measure of the surface charge of mycobacterial cells. Ann. Microbiol. 64, 1189–1195 (2014).
doi: 10.1007/s13213-013-0758-y
Shi, W. et al. Dairy processing sludge and co-products: A review of present and future re-use pathways in agriculture. J. Clean. Prod. 314, 128035 (2021).
doi: 10.1016/j.jclepro.2021.128035
Ly, M., Margaritis, A. & Jajuee, B. Effect of solvent concentration on the extraction kinetics and diffusivity of cyclosporin A in the fungus Tolypocladium inflatum. Biotechnol. Bioeng. 96, 67–79 (2007).
pubmed: 16948167
doi: 10.1002/bit.21180
Falah, F. et al. Effect of immobilization, mutation, and microbial stresses on increasing production efficiency of “cyclosporin A”. Biomass Convers. Biorefin. 14, 1–16 (2022).
Geankoplis, C. Process Principles (Prentice Hall, 2003).
Balaraman, K. & Mathew, N. Optimization of media composition for the production of cyclosporin A by Tolypocladium species. Indian J. Med. Res. 123, 525 (2006).
pubmed: 16783043
Sharmila, K., Thillaimaharani, K., Logesh, A., Sathishkumar, A. & Kalaiselvam, M. Production of cyclosporin A by saprophytic filamentous fungus Fusarium oxysporum. Int. J. Pharm. Pharm. Sci. 4, 149–153 (2012).
Shetty, P. R., Buddana, S. K., Tatipamula, V. B., Naga, Y. V. V. & Ahmad, J. Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity. Braz. J. Microbiol. 45, 303–312 (2014).
pubmed: 24948949
pmcid: 4059315
doi: 10.1590/S1517-83822014005000022
Seger, C. & Salzmann, L. After another decade: LC–MS/MS became routine in clinical diagnostics. Clin. Biochem. 82, 2–11 (2020).
pubmed: 32188572
doi: 10.1016/j.clinbiochem.2020.03.004
Poquette, M. A., Lensmeyer, G. L. & Doran, T. C. Effective use of liquid chromatography–mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine. Ther. Drug Monit. 27, 144–150 (2005).
pubmed: 15795643
doi: 10.1097/01.ftd.0000148451.35811.74
Li, W. et al. A comparison of liquid chromatography–tandem mass spectrometry (LC–MS/MS) and enzyme-multiplied immunoassay technique (EMIT) for the determination of the cyclosporin A concentration in whole blood from Chinese patients. Biosci. Trends 11, 475–482 (2017).
pubmed: 28845016
doi: 10.5582/bst.2017.01121
Buchwald, A., Winkler, K. & Epting, T. Validation of an LC–MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. BMC Clin. Pharmacol. 12, 1–11 (2012).
doi: 10.1186/1472-6904-12-2
Koster, R. A., Alffenaar, J.-W.C., Greijdanus, B. & Uges, D. R. Fast LC–MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. Talanta 115, 47–54 (2013).
pubmed: 24054560
doi: 10.1016/j.talanta.2013.04.027
Abrol, V., Kushwaha, M., Mallubhotla, S. & Jaglan, S. Chemical mutagenesis and high throughput media optimization in Tolypocladium inflatum MTCC-3538 leads to enhanced production of cyclosporine A. 3 Biotech 12, 1–8 (2022).
doi: 10.1007/s13205-022-03219-x
Lam, K. B., Le Blanc, J. Y. & Campbell, J. L. Separating isomers, conformers, and analogues of cyclosporin using differential mobility spectroscopy, mass spectrometry, and hydrogen–deuterium exchange. Anal. Chem. 92, 11053–11061 (2020).
pubmed: 32698568
doi: 10.1021/acs.analchem.0c00191
Başaran, E., Yenilmez, E., Berkman, M. S., Büyükköroğlu, G. & Yazan, Y. Chitosan nanoparticles for ocular delivery of cyclosporine A. J. Microencapsul. 31, 49–57 (2014).
pubmed: 23834316
doi: 10.3109/02652048.2013.805839
Efimov, S., Karataeva, F. K., Aganov, A., Berger, S. & Klochkov, V. Spatial structure of cyclosporin A and insight into its flexibility. J. Mol. Struct. 1036, 298–304 (2013).
doi: 10.1016/j.molstruc.2012.11.005
Sinnaeve, D., Foroozandeh, M., Nilsson, M. & Morris, G. A. A general method for extracting individual coupling constants from crowded 1H NMR spectra. Angew. Chem. 128, 1102–1105 (2016).
doi: 10.1002/ange.201508691
Ohta, K., Agematu, H., Yamada, T., Kaneko, K. & Tsuchida, T. Production of human metabolites of cyclosporin A, AM1, AM4N and AM9, by microbial conversion. J. Biosci. Bioeng. 99, 390–395 (2005).
pubmed: 16233807
doi: 10.1263/jbb.99.390
Gendron, A. et al. New nanoparticle formulation for cyclosporin A: In vitro assessment. Pharmaceutics 13, 91 (2021).
pubmed: 33445646
pmcid: 7828155
doi: 10.3390/pharmaceutics13010091
Pilz, S. et al. Rationale and plan for vitamin D food fortification: A review and guidance paper. Front. Endocrinol. 9, 373 (2018).
doi: 10.3389/fendo.2018.00373
Jenkins, A. L., Larsen, R. A. & Williams, T. B. Characterization of amino acids using Raman spectroscopy. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 61, 1585–1594 (2005).
doi: 10.1016/j.saa.2004.11.055
Lechuga-Ballesteros, D., Abdul-Fattah, A., Stevenson, C. L. & Bennett, D. B. Properties and stability of a liquid crystal form of cyclosporine—the first reported naturally occurring peptide that exists as a thermotropic liquid crystal. J. Pharm. Sci. 92, 1821–1831 (2003).
pubmed: 12950000
doi: 10.1002/jps.10444
Guada, M. et al. Ultra high performance liquid chromatography–tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems. J. Chromatogr. B 927, 164–172 (2013).
doi: 10.1016/j.jchromb.2013.02.001
Jain, S., Mittal, A., Jain, A. K., Mahajan, R. R. & Singh, D. Cyclosporin A loaded PLGA nanoparticle: Preparation, optimization, in-vitro characterization and stability studies. Curr. Nanosci. 6, 422–431 (2010).
doi: 10.2174/157341310791658937
Saliba, J. B. et al. Characterization and in vitro release of cyclosporine-A from poly (D, L-lactide-co-glycolide implants obtained by solvent/extraction evaporation. Química Nova 35, 723–727 (2012).
doi: 10.1590/S0100-40422012000400013
Stevenson, C. L., Bennett, D. B. & Lechuga-Ballesteros, D. Pharmaceutical liquid crystals: The relevance of partially ordered systems. J. Pharm. Sci. 94, 1861–1880 (2005).
pubmed: 16052511
doi: 10.1002/jps.20435
Li, Y. et al. In vitro and in vivo studies of cyclosporin A-loaded microspheres based on copolymers of lactide and ɛ-caprolactone: Comparison with conventional PLGA microspheres. Int. J. Pharm. 295, 67–76 (2005).
pubmed: 15847992
doi: 10.1016/j.ijpharm.2005.01.025
Dubey, P., Barker, S. A. & Craig, D. Q. Design and characterization of cyclosporine A-loaded nanofibers for enhanced drug dissolution. ACS Omega 5, 1003–1013 (2020).
pubmed: 31984256
pmcid: 6977102
doi: 10.1021/acsomega.9b02616
Sun, J. et al. Effect of particle size on solubility, dissolution rate, and oral bioavailability: Evaluation using coenzyme Q10 as naked nanocrystals. Int. J. Nanomed. 7, 5733 (2012).
Lei, Y. et al. Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: Preparation, characterization and in vitro redispersibility. Int. J. Nanomed. 6, 795 (2011).